PDF(Pubmed)
Abstract：
BACKGROUND: It remains unclear how patients with atopic dermatitis (AD) and clinicians perceive the level of patient-clinician communication and if there could be potential lapses. This cross-sectional study aims to compare perspectives between patients with AD and dermatologists regarding communication and treatment expectations in Asia.
METHODS: Moderate-to-severe patients with AD and practicing dermatologists were recruited from eight Asia-Pacific territories, including Mainland China, Hong Kong, India, Japan, Singapore, South Korea, Taiwan, and Thailand. Patients and dermatologists completed separate surveys designed to elicit their expectations regarding AD management, and their perceived level of patient-clinician communication. Patients were also asked about their treatment satisfaction and whether they prefer additional treatment beyond what was prescribed. Demographic information and responses were analyzed using descriptive statistics. The study was reviewed by the institutional review board in each territory, and all participants provided informed consent.
RESULTS: A total of 1103 patients and 271 dermatologists completed the surveys. Both patients and dermatologists were largely aligned in their top treatment goals in AD management. However, greater proportions of patients prioritized the prevention of exacerbation (78.0% versus 47.2%), minimization of treatment adverse effects (46.4% versus 9.1%), and improvement in mental health (16.0% versus 4.9%), compared with dermatologists. Although patient-clinician communication was observed to be generally good, 10.9% of patients reported dissatisfaction with communication in AD management. The majority of patients were either \"very satisfied\" or \"satisfied\" with their latest acute AD treatment, but 65.5% of patients still desired additional treatment.
CONCLUSIONS: This multinational study has provided insights on the perspectives of Asian patients and dermatologists in treatment goals, AD management, and communication. In general, both patients and dermatologists were aligned in treatment goals and there was satisfactory patient-clinician communication in most aspects. However, potential areas of improvement have been identified to further enhance patient-centered care.
METHODS: Moderate-to-severe patients with AD and practicing dermatologists were recruited from eight Asia-Pacific territories, including Mainland China, Hong Kong, India, Japan, Singapore, South Korea, Taiwan, and Thailand. Patients and dermatologists completed separate surveys designed to elicit their expectations regarding AD management, and their perceived level of patient-clinician communication. Patients were also asked about their treatment satisfaction and whether they prefer additional treatment beyond what was prescribed. Demographic information and responses were analyzed using descriptive statistics. The study was reviewed by the institutional review board in each territory, and all participants provided informed consent.
RESULTS: A total of 1103 patients and 271 dermatologists completed the surveys. Both patients and dermatologists were largely aligned in their top treatment goals in AD management. However, greater proportions of patients prioritized the prevention of exacerbation (78.0% versus 47.2%), minimization of treatment adverse effects (46.4% versus 9.1%), and improvement in mental health (16.0% versus 4.9%), compared with dermatologists. Although patient-clinician communication was observed to be generally good, 10.9% of patients reported dissatisfaction with communication in AD management. The majority of patients were either \"very satisfied\" or \"satisfied\" with their latest acute AD treatment, but 65.5% of patients still desired additional treatment.
CONCLUSIONS: This multinational study has provided insights on the perspectives of Asian patients and dermatologists in treatment goals, AD management, and communication. In general, both patients and dermatologists were aligned in treatment goals and there was satisfactory patient-clinician communication in most aspects. However, potential areas of improvement have been identified to further enhance patient-centered care.
摘要：
背景：目前尚不清楚特应性皮炎（AD）患者和临床医生如何看待患者与临床医生的沟通水平，以及是否存在潜在的失误。这项横断面研究旨在比较亚洲AD患者和皮肤科医生对沟通和治疗期望的看法。
方法：从八个亚太地区招募中度至重度AD患者和执业皮肤科医生，包括中国大陆，香港,印度,Japan,新加坡,韩国,台湾,和泰国。患者和皮肤科医生完成了单独的调查，旨在激发他们对AD管理的期望。以及他们感知的患者-临床医生沟通水平。患者还被问及他们的治疗满意度，以及他们是否更喜欢超出处方的额外治疗。使用描述性统计对人口统计信息和反应进行分析。该研究由每个地区的机构审查委员会审查，所有参与者均提供知情同意书。
结果：共有1103名患者和271名皮肤科医生完成了调查。患者和皮肤科医生在AD管理中的最高治疗目标在很大程度上是一致的。然而,更多的患者优先预防恶化(78.0%对47.2%)，将治疗不良反应降至最低(46.4%对9.1%)，心理健康改善(16.0%对4.9%)，与皮肤科医生相比。尽管观察到患者与临床医生的沟通总体良好，10.9%的患者报告对AD管理中的沟通不满意。大多数患者对他们最新的急性AD治疗“非常满意”或“满意”。但65.5%的患者仍需要额外的治疗。
结论：这项跨国研究为亚洲患者和皮肤科医生在治疗目标方面的观点提供了见解，AD管理,和沟通。总的来说,患者和皮肤科医师的治疗目标一致,患者-临床医师沟通在大多数方面都令人满意.然而,已经确定了潜在的改进领域,以进一步加强以患者为中心的护理.
方法：从八个亚太地区招募中度至重度AD患者和执业皮肤科医生，包括中国大陆，香港,印度,Japan,新加坡,韩国,台湾,和泰国。患者和皮肤科医生完成了单独的调查，旨在激发他们对AD管理的期望。以及他们感知的患者-临床医生沟通水平。患者还被问及他们的治疗满意度，以及他们是否更喜欢超出处方的额外治疗。使用描述性统计对人口统计信息和反应进行分析。该研究由每个地区的机构审查委员会审查，所有参与者均提供知情同意书。
结果：共有1103名患者和271名皮肤科医生完成了调查。患者和皮肤科医生在AD管理中的最高治疗目标在很大程度上是一致的。然而,更多的患者优先预防恶化(78.0%对47.2%)，将治疗不良反应降至最低(46.4%对9.1%)，心理健康改善(16.0%对4.9%)，与皮肤科医生相比。尽管观察到患者与临床医生的沟通总体良好，10.9%的患者报告对AD管理中的沟通不满意。大多数患者对他们最新的急性AD治疗“非常满意”或“满意”。但65.5%的患者仍需要额外的治疗。
结论：这项跨国研究为亚洲患者和皮肤科医生在治疗目标方面的观点提供了见解，AD管理,和沟通。总的来说,患者和皮肤科医师的治疗目标一致,患者-临床医师沟通在大多数方面都令人满意.然而,已经确定了潜在的改进领域,以进一步加强以患者为中心的护理.
